Related references
Note: Only part of the references are listed.Targeting p53 for the treatment of cancer
Michael J. Duffy et al.
SEMINARS IN CANCER BIOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Current developments of targeting the p53 signaling pathway for cancer treatment
Jing Huang
PHARMACOLOGY & THERAPEUTICS (2021)
FAT10: Function and Relationship with Cancer
Senfeng Xiang et al.
CURRENT MOLECULAR PHARMACOLOGY (2020)
Ubiquitin-like protein FAT10 promotes osteosarcoma growth by modifying the ubiquitination and degradation of YAP1
Xuan Yi et al.
EXPERIMENTAL CELL RESEARCH (2020)
IFNγ potentiates TNFα/TNFR1 signaling to induce FAT10 expression in macrophages
Michal Kandel-Kfir et al.
MOLECULAR IMMUNOLOGY (2020)
p53: 800 million years of evolution and 40 years of discovery
Arnold J. Levine
NATURE REVIEWS CANCER (2020)
The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs
Martha L. Slattery et al.
GENOMICS (2019)
UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10
Fengting Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
Hui Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinicopathological significance of human leukocyte antigen F-associated transcript 10 expression in colorectal cancer
Chun-Yang Zhang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression
Jinlong Yan et al.
HEPATOLOGY (2018)
The family of apoptosis-stimulating proteins of p53 is dysregulated in colorectal cancer patients
Libin Yin et al.
ONCOLOGY LETTERS (2018)
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
Annette Aichem et al.
NATURE COMMUNICATIONS (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis
Cheng Xing et al.
CANCER RESEARCH (2016)
The ubiquitin-like modifier FAT10 in cancer development
Annette Aichem et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin
Dingxiang Dong et al.
ONCOTARGET (2016)
p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer
Shilei Wen et al.
ONCOTARGET (2016)
Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy
Senlin Zhao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
Tao Han et al.
ONCOTARGETS AND THERAPY (2015)
FAT10ylation as a signal for proteasomal degradation
Gunter Schmidtke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53
Yongwook Choi et al.
MOLECULAR ONCOLOGY (2014)
Ubiquitination in disease pathogenesis and treatment
Doris Popovic et al.
NATURE MEDICINE (2014)
Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
Qin Li et al.
CLINICAL CANCER RESEARCH (2013)
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Mark Wade et al.
NATURE REVIEWS CANCER (2013)
The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation
Frederic Ebstein et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation
Annette Aichem et al.
JOURNAL OF CELL SCIENCE (2012)
FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis
Neha Rani et al.
NATURE COMMUNICATIONS (2012)
FAT10 modifies p53 and upregulates its transcriptional activity
Tianwei Li et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
D-W Yan et al.
BRITISH JOURNAL OF CANCER (2010)
The multiple levels of regulation by p53 ubiquitination
J. T. Lee et al.
CELL DEATH AND DIFFERENTIATION (2010)
USE1 is a bispecifi c conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis
Annette Aichem et al.
NATURE COMMUNICATIONS (2010)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging
Feng Ji et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
E1-L2 activates both ubiquitin and FAT10
Yu-Hsin Chiu et al.
MOLECULAR CELL (2007)
p53: Guardian of the genome and policeman of the oncogenes
Alejo Efeyan et al.
CELL CYCLE (2007)
Coping with stress: multiple ways to activate p53
H. F. Horn et al.
ONCOGENE (2007)
p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers
DW Zhang et al.
ONCOGENE (2006)
FAT10, a ubiquitin-independent signal for proteasomal degradation
MS Hipp et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Expression of the FAT 10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers
CGL Lee et al.
ONCOGENE (2003)
Share Paper
